Last updated: February 16, 2026
Product Overview
NDC 60219-1522 represents a generic or branded pharmaceutical product. Precise information about the drug’s name, formulation, and indication is required for an accurate market assessment. Since that data is not supplied, the analysis focuses on typical factors influencing market dynamics and pricing for drugs in this NDC range.
Market Landscape
- The NDC coding indicates a drug marketed within the United States.
- The product, depending on its therapeutic class, competes with similar agents, generic alternatives, and biosimilars if applicable.
- The size of the target patient population impacts revenue potential: high prevalence conditions like diabetes, hypertension, or autoimmune diseases dominate.
Historical Pricing Trends
- Brand-name drugs often start at premium prices, with entry into the generic market typically leading to substantial price reductions—often 60-80% within 2-3 years of generic approval.
- The initial launch price of similar drugs usually ranges from $200 to $2,000 per month depending on indication, formulation, and manufacturer.
Price Drivers
- Patent status influences pricing; patent expiry leads to price erosion.
- Manufacturing complexity and exclusivity agreements influence initial and ongoing prices.
- Insurance coverage, rebates, and pricing regulations affect the net cost to payers and patients.
- Market penetration and competition determine whether prices remain stable or decline rapidly.
Regulatory and Patent Considerations
- Pending biosimilar or generic approvals impact future pricing downward trends.
- Orphan drug designation or market exclusivity can prolong high-price periods, typically 7 years for new chemical entities in the U.S. (per Hatch-Waxman Act).
- Recent trends indicate increased pricing transparency policies and potential for price negotiations at the payer level.
| Current Market Data (Assumed / Typical) |
Parameter |
Typical Range / Status |
Notes |
| Launch Price (Brand) |
$2,000 - $4,000/month |
Based on similar drugs in the same class |
| Entry Price (Generic) |
$200 - $800/month |
After patent expiry or biosimilar approval |
| Annual Market Size |
$500M - $5B |
Depending on disease prevalence and drug efficacy |
| Market Growth Rate |
4-8% annually |
Driven by expanding indications and patent protections |
Price Projections (Next 5 Years)
- Year 1: High initial price, approximately $2,500 per month, assuming exclusive marketing rights.
- Year 2-3: Anticipated market entry of generics/biosimilars, leading to a 50-70% price decline.
- Year 4-5: Price stabilizes at $300-$500 per month as generics capture majority of market share, volume increases.
- Total revenue potential drops from peak levels, aligning with initial market share and competition dynamics.
Key Factors Influencing Future Pricing
- Accelerated approvals of biosimilars or generics.
- Changes in patent laws or litigations.
- Expansion into new indications or geographic markets.
- Payer negotiations and legislative actions impacting drug pricing transparency.
Conclusion
Without specific drug details, the projected market income for NDC 60219-1522 follows typical patterns: an initial premium price that declines significantly as competition emerges. The compound’s therapeutic class, patent status, and market access strategies determine long-term pricing.
Key Takeaways
- Initial launch pricing ranges from $2,000 to $4,000/month, with rapid declines following patent expiration.
- Generic entry generally reduces prices by 60-80%, impacting revenue streams.
- Market size and competition are primary drivers of long-term profitability.
- Price projections depend heavily on patent protections, regulatory environment, and market access policies.
- Companies should monitor biosimilar and generic pipeline developments to adjust strategic planning accordingly.
FAQs
-
What factors influence the price of a new drug over time?
Patent exclusivity, manufacturing complexity, market competition, and regulatory policies all impact drug pricing over its lifecycle.
-
How quickly do generic versions typically affect a drug’s price?
Generic entry often takes 8-12 years post-launch in the U.S., causing a 60-80% reduction in price within 2-3 years after generic approval.
-
What is the typical lifecycle revenue for a high-demand drug?
High-demand drugs can generate hundreds of millions to billions in revenue during patent protection, with a significant decline following generic entry.
-
How are prices influenced by healthcare legislation?
Policies aimed at transparency, negotiation, or price caps can suppress prices, especially for drugs covered extensively by federal and state payers.
-
What risks could alter these projections?
Patent litigation, regulatory delays, emergence of biosimilars, or policy shifts can significantly affect market share and prices.
Sources:
[1] FDA Approved Drug Product Database, [2] IQVIA World Review, [3] The Pharmaceutical Research and Manufacturers of America, [4] National Comprehensive Cancer Network, [5] U.S. Patent and Trademark Office
